Drugs for bone healing

Bibliography

• MacKenzie EJ, Bosse MJ, Pollak AN, Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-up. J Bone Joint Surg Am 2005;87:1801-9
   PubMed Web of Science ®Google Scholar
• Parfitt AM. Osteonal and hemi-osteonal remodelling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994;55:273-86
   PubMed Web of Science ®Google Scholar
• Al-Aql ZS, Alagl AS, Graves DT, Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008;87:107-18
   PubMed Web of Science ®Google Scholar
• Ferguson C, Alpern E, Miclau T, Hels JA. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 1999;87:57-66
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Cullinane DM, Barnes GL, Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of ist regulation. J Cell Biochem 2003;88:873-84
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Alkhiary YM, Krall EA, Three-dimensional reconstruction of fracture callus morphogenesis. J Histochem Cytochem 2006;54:1215-28
   PubMed Web of Science ®Google Scholar
• Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005;36:1392-404
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration: Medical Devices. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/default.htm
   Google Scholar
• Nauth A, Giannoudis PV, Einhorn TA, Growth factors: beyond bone morphogenetic proteins. J Orthop Trauma 2010;24:543-6
   PubMed Web of Science ®Google Scholar
• Simpson AH, Mlls L, Noble B. The role of growth factors and related agents in accelerating fracture healing. J Bone Joint Surg Br 2006;88:701-5
   PubMedGoogle Scholar
• Blokhuis TJ. Formulations and delivery vehicles for bone morphogenetic proteins: latest advances and future directions. Injury 2009;40:S8-11
   PubMed Web of Science ®Google Scholar
• Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration current concepts and future directions. BMC Med 2011;9:66-76
   PubMed Web of Science ®Google Scholar
• Alsousou J, Thompson M, Hulley P, The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 2009;91:987-96
   PubMed Web of Science ®Google Scholar
• Vavken P, Sadoghi P, Murray MM. The effect of platelet concentrates on graft maturation and graft-bone interface healing in anterior cruciate ligament reconstruction in human patients: a systematic review of controlled trials. J Arthrosc Rel Surg 2011;27:1573-83
   PubMed Web of Science ®Google Scholar
• Agintar E, Edwards S, Delahay J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2010;42(8):730-4
   PubMed Web of Science ®Google Scholar
• Chen FM, Ma ZW, Dong GY, Wu ZF. Composite glycidyl methacrylated dextran (DexGMA)/gelatin nanoparticles for localized protein delivery. Acta Pharmacol Sin 2009;30:485-93
   PubMed Web of Science ®Google Scholar
• Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury 2007;3854:53-6
   Google Scholar
• Hernigou PH, Poignard A, Beaujean E, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. J Bone Joint Surg 2005;87A:1430-7
   Web of Science ®Google Scholar
• Charbord P, Livne E, Gross G, Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev Rep 2011;7:32-42
   PubMed Web of Science ®Google Scholar
• Aspenberg P. Drugs and fracture repair. Acta Orthop 2005;76-6:741-8
   Web of Science ®Google Scholar
• Einhorn TA. Enhancement of fracture-healing. J Bone Joint Surg Am 1995;77:6:940-56
   PubMed Web of Science ®Google Scholar
• Jorgensen NR, Schwarz P. Effects of anti-osteoporosis medications on fracture healing. Curr Osteoporos Rep 2011;9:149-55
   PubMedGoogle Scholar
• Bukata SV. Systemic administration of pharmacological agents and bone repair: what can we expect. Injury 2011;42:605-8
   PubMed Web of Science ®Google Scholar
• Goldhahn J, Mitlak BH, Asperberg P, Critical issues in translational and clinical research for the study of new technologies to enhance bone repair. J Bone Joint Surg Am 2008;90:40-3
   PubMedGoogle Scholar
• Goldhahn J, Scheele WH, Mitlak BH, Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone 2008;43:343-7
   PubMed Web of Science ®Google Scholar
• Goldhahn J, Little D, Mitchell P, Evidence for anti-osteoporosis therapy in acute fracture situations-recommendations of a multidisciplinary workshop of the International Society for Fracture Repair. Bone 2010;46:267-71
   PubMed Web of Science ®Google Scholar
• Ferguson C, Alpern E, Miclau T, Helms JA. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 1999;87:57-66
   PubMed Web of Science ®Google Scholar
• Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;355:S7-21
   PubMed Web of Science ®Google Scholar
• Adams GB, Martin RP, Alley IR, Therapeutic targeting of a stem cell niche. Nature Biotechnol 2007;25:238-43
   PubMed Web of Science ®Google Scholar
• Butcher JL, MacKenzie EJ, Cushing B, Long-term outcomes after low extremity trauma. J Trauma 1996;41:4-9
   PubMed Web of Science ®Google Scholar
• MacKenzie EJ, Bosse MJ, Pollak AN, Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-up. J Bone Joint Surg Am 2005;87:1801-9
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22
   PubMed Web of Science ®Google Scholar
• Craig SJ, Youssef PP, Vaile JH, Intravenous zoledronate and oral alendronate in patients with a low trauma fracture- experience from an osteoporosis clinic. Intern Med J 2010;41:186-90
   Web of Science ®Google Scholar
• Cao Y, Mori S, Mashiba T, Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 2002;17:2237-46
   PubMed Web of Science ®Google Scholar
• Langeland N. Effects of oestradiol-17 beta benzoate treatment on fracture healing and bone collagen synthesis in female rats. Acta Endocrinol (Copenh) 1975;80:603-12
   PubMedGoogle Scholar
• Meyer RA Jr, Tsahakis PJ, Martin DF, Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats. J Orthop Res 2001;19:428-35
   PubMed Web of Science ®Google Scholar
• Yingjie H, Ge Z, Yisheng W, Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 2007;41:631-8
   PubMed Web of Science ®Google Scholar
• Bannister GC, Gibson AG, Ackroyd CE, The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop Relat Res 1990;254:242-6
   PubMed Web of Science ®Google Scholar
• Sadowski C, Lubbeke A, Saudan M, Treatment of reverse oblique and transverse intertrochanteric fractures with use of an intramedullary nail or a 95 degrees screwplate: a prospective, randomized study. J Bone Joint Surg Am 2002;84-A:372-81
   PubMedGoogle Scholar
• Schmidmaier G, Lucke M, Schwabe P, Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-9
   PubMedGoogle Scholar
• Kais MS, Einhorn TA. Recombinant human bone morphogenetic proteins in the treatment of fractures. Foot Ankle Clin 2005;10:639-50; viii
   PubMedGoogle Scholar
• Shane E, Burr D, Ebeling PR, Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010;25:2267-94
   PubMed Web of Science ®Google Scholar
• Goodship AE, Walker PC, McNally D, Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol 1994;5(Suppl 7):S53-5
   PubMedGoogle Scholar
• Nauth A, Miclau T, Bhandari M, Schemitsch EH. Use of osteobiologics in the management of osteoporotic fractures. J Orthop Trauma 2011;25:S51-5
   PubMed Web of Science ®Google Scholar
• Kinov P, Tivchev P, Doukova P, Leithner A. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomized study. Arch Orthop Belg 2006;72:44-50
   PubMedGoogle Scholar
• Hilding M, Aspenberg P. Local preoperative treatment with bisphosphonate improves the fixation of total knee prostheses. Acta Orthoped 2007;78:795-9
   PubMed Web of Science ®Google Scholar
• Solomon HMC, Mogun H, Schneeweiss S. The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Intv 2009;20:895-201
   PubMed Web of Science ®Google Scholar
• Moroni A, Faldini C, Hoang-Kim A, Alendronate improves screw fixation in osteoporotic bone. J Bone Joint Surg Am 2007;89:96-101
   PubMed Web of Science ®Google Scholar
• Rozental TD, Vazquez MA, Chacko AT, Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am 2009;34:595-602
   PubMed Web of Science ®Google Scholar
• Colon-Emeric C, Nordsletten L, Olson S, Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 2010;22(8):2329-36
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Sacks DJ, Pelis M, Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 2009;24:196-208
   PubMed Web of Science ®Google Scholar
• Stuermer EK, Sehmisch S, Rack T, Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in the rat. Langenbecks Arch Surg 2010;395:163-72
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zancgetta JR, Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Bone HG, Ettinger MP, Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 2007;146:326-39
   PubMed Web of Science ®Google Scholar
• Ellegaard M, Jorgensen NR, Scwarz P. Parathyroid hormone and bone healing. Calcif Tissue Int 2010;87:1-13
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Genant HK, Johansson T, Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010;25:404-14
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radius fractures. Analysis of a subgroup of patients within a randomized trial. Acta Orthopaed 2010;81:234-6
   PubMed Web of Science ®Google Scholar
• Resmini G, Iolascon G. 79-year-old post-menopausal woman with humerus fracture during teriparatide treatment. Aging Clin Exp Res 2007;19(4 Suppl):30-1
   PubMedGoogle Scholar
• Hodsman AB, Hanley DA, Ettinger MP, Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 2003;88:5212-20
   PubMed Web of Science ®Google Scholar
• Whitfield JF, Morley P, Willick G, Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats. J Bone Miner Res 1997;12:1246-52
   PubMed Web of Science ®Google Scholar
• Peichl P, Holzer LA, Maier R, Olzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg 2011;93:1583-7
   PubMed Web of Science ®Google Scholar
• Li YF, Zhou CC, Li JH, The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. Osteoporos Int 2011. [Epub ahead of print]
   Web of Science ®Google Scholar
• Meunier PJ, Roux C, Seeman E, The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-68
   PubMed Web of Science ®Google Scholar
• Maimoun L, Brennan TC, Badoud I, Strontium ranelate improves implant osseointegration. Bone 2010;46:1436-41
   PubMed Web of Science ®Google Scholar
• Li Y, Feng G, Gao Y, Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 2010;28:578-82
   PubMed Web of Science ®Google Scholar
• Cebesoy O, Tutar E, Kose KC, Effect of strontium ranelate on fracture healing in rat tibia. Joint Bone Spine 2007;74:590-3
   PubMed Web of Science ®Google Scholar
• Li YF, Luo E, Zhu SS, Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int 2010;21:1889-97
   PubMed Web of Science ®Google Scholar
• Bruel A, Olsen J, Birkedal H, Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures. Calcif Tissue Int 2011;88:142-52
   PubMed Web of Science ®Google Scholar
• Habermann B, Kafchitsas K, Olender G, Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 2010;86:82-9
   PubMed Web of Science ®Google Scholar
• Alegre DN, Ribeiro C, Sousa C, Possible benefits of strontium ranelate in complicated long bone fractures. Rheumatol Int 2012;32:439-43
   PubMed Web of Science ®Google Scholar
• Tarantino U, Celi M, Saturnino L, Strontium ranelate and bone healing: report of two cases. Clin Cases Miner Bone Metab 2010;7:65-8
   Google Scholar
• Komatsu DE, Mary MN, Schroeder RJ, Modulation of Wnt signaling influences fracture repair. J Orthop Res 2010;28:928-36
   PubMed Web of Science ®Google Scholar
• Ominsky MS, Li C, Li X, Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res 2011;26:1012-21
   PubMed Web of Science ®Google Scholar
• Kumar S, Matheny CJ, Hoffman SJ, An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone 2010;46:534-42
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LA, Brennan E, Kumar S, Ronacaleret, a novel calcium-sensing receptor antagonist, demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women. J Bone Miner Res 2008;23:S50
   Web of Science ®Google Scholar
• Bone Fitzpatrick LA, Smith PL, McBride TA, Ronacarelet, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trial. Bone 2011;49:845-52
   PubMed Web of Science ®Google Scholar
• Takahata M, Schwarz EM, Chen T, Delayed short course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction. J Bone Miner Res 2011;27:26-37
   Web of Science ®Google Scholar